Siim Land: David Sinclair’s Cellular Reprogramming: Another Hype Cycle or Real Progress?
S Siim Land Video Summary · April 13, 2026 View Full Protocol → Key Takeaways Monitor David Sinclair’s ongoing clinical trials for ER-100, focusing on its potential to reverse aging in humans, with results expected by 2032. Stay updated on the outcomes of FDA-approved human trials for ER-100 in treating optic nerve conditions like glaucoma…
